StockData
Accendra Health Inc logo

Accendra Health Inc (ACH) stock

ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)

Close on Nov 13, 2026Market cap $10.00MP/E –Yield –

Accendra Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Accendra Health's operating income for the twelve months ending Sep 30, 2026 was $4.22M. For fiscal 2025 it was $27.46M. Over ten years it grew -18.0% a year on average. The highest annual figure on record is $368.47M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$27.46M–
FY2024Dec 31, 2024-$217.73M-263.4%
FY2023Dec 31, 2023$133.23M-6.8%
FY2022Dec 31, 2022$142.91M-61.2%
FY2021Dec 31, 2021$368.47M+80.5%
FY2020Dec 31, 2020$204.12M+179.0%
FY2019Dec 31, 2019$73.15M–
FY2018Dec 31, 2018-$352.35M-494.8%
FY2017Dec 31, 2017$89.25M-55.3%
FY2016Dec 31, 2016$199.60M-0.4%
FY2015Dec 31, 2015$200.36M+25.6%
FY2014Dec 31, 2014$159.54M-19.5%
FY2013Dec 31, 2013$198.08M+0.7%
FY2012Dec 31, 2012$196.75M-3.3%
FY2011Dec 31, 2011$203.52M+3.9%
FY2010Dec 31, 2010$195.94M-2.7%
FY2009Dec 31, 2009$201.28M+11.4%
FY2008Dec 31, 2008$180.73M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.33M-95.0%
Q2 FY2026Jun 30, 2026-$35.15M–
Q1 FY2026Mar 31, 2026$17.13M-13.5%
Q4 FY2025Dec 31, 2025$20.91M–
Q3 FY2025Sep 30, 2025$26.47M-14.8%
Q2 FY2025Jun 30, 2025-$39.71M-334.7%
Q1 FY2025Mar 31, 2025$19.79M+104.1%
Q4 FY2024Dec 31, 2024-$272.70M-407.3%
Q3 FY2024Sep 30, 2024$31.08M+30.4%
Q2 FY2024Jun 30, 2024$16.92M+56.1%
Q1 FY2024Mar 31, 2024$9.70M-1.1%
Q4 FY2023Dec 31, 2023$88.74M–
Q3 FY2023Sep 30, 2023$23.84M-60.4%
Q2 FY2023Jun 30, 2023$10.84M-85.6%
Q1 FY2023Mar 31, 2023$9.81M-83.9%
Q4 FY2022Dec 31, 2022-$53.48M-186.2%
Q3 FY2022Sep 30, 2022$60.25M-4.2%
Q2 FY2022Jun 30, 2022$75.09M-22.5%
Q1 FY2022Mar 31, 2022$61.06M-58.4%
Q4 FY2021Dec 31, 2021$62.02M-35.1%
Q3 FY2021Sep 30, 2021$62.88M-16.8%
Q2 FY2021Jun 30, 2021$96.88M+336.5%
Q1 FY2021Mar 31, 2021$146.69M+1263.8%
Q4 FY2020Dec 31, 2020$95.61M+557.6%
Q3 FY2020Sep 30, 2020$75.55M+189.4%
Q2 FY2020Jun 30, 2020$22.20M+39.6%
Q1 FY2020Mar 31, 2020$10.76M-35.2%
Q4 FY2019Dec 31, 2019$14.54M–
Q3 FY2019Sep 30, 2019$26.11M+22.3%
Q2 FY2019Jun 30, 2019$15.90M–
Q1 FY2019Mar 31, 2019$16.60M-31.4%
Q4 FY2018Dec 31, 2018-$225.87M–
Q3 FY2018Sep 30, 2018$21.36M-28.0%
Q2 FY2018Jun 30, 2018-$172.05M-624.0%
Q1 FY2018Mar 31, 2018$24.22M-31.8%
Q4 FY2017Dec 31, 2017-$8.77M-117.9%
Q3 FY2017Sep 30, 2017$29.67M–
Q2 FY2017Jun 30, 2017$32.84M–
Q1 FY2017Mar 31, 2017$35.52M–
Q4 FY2016Dec 31, 2016$49.01M–

More Accendra Health figures

See a number that looks wrong?